Zydus Lifesciences Recalls

6 recalls found for Zydus Lifesciences. Check if any of your products are affected.

HIGHFDA DRUG

Zydus Lifesciences Recalls Tavaborole Topical Solution Over Discoloration

Zydus Lifesciences recalled 13,080 bottles of Tavaborole topical solution on October 6, 2025, due to discoloration. The recall affects products distributed nationwide in the USA. Consumers must stop using the product immediately and contact their healthcare providers for guidance.

Zydus Lifesciences
Discoloration -
Read more
HIGHFDA DRUG

Zydus Lifesciences Recalls Chlorpromazine Tablets Due to Hazard

Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets contain N-Nitroso Desmethyl Chlorpromazine above safe intake levels. Consumers must stop using the product immediately and consult healthcare providers.

Zydus Lifesciences
CGMP Deviations:
Read more
HIGHFDA DRUG

Zydus Lifesciences Recalls Chlorpromazine Tablets Due to Contamination

Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets containing N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.

Zydus Lifesciences
CGMP Deviations:
Read more
HIGHFDA DRUG

Zydus Lifesciences Recalls Chlorpromazine Tablets Over Chemical Hazard

Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.

Zydus Lifesciences
CGMP Deviations:
Read more
HIGHFDA DRUG

Zydus Lifesciences Recalls Chlorpromazine Tablets Over Contaminant Hazard

Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets with NDC 16714-051-01 due to N-Nitroso Desmethyl Chlorpromazine exceeding acceptable limits. Consumers should stop using the product immediately and consult healthcare providers.

Zydus Lifesciences
CGMP Deviations:
Read more
HIGHFDA DRUG

Zydus Recalls Chlorpromazine Hydrochloride Tablets Over Contamination Hazard

Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 10 mg tablets sold nationwide due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and consult healthcare providers.

Zydus Lifesciences
CGMP Deviations:
Read more

Brand Statistics

Total Recalls
6
Pages
1